Clinical Trial Update: A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study comparing the pharmacokinetics and pharmacodynamics of LY2963016 to Lantus (insulin glargine) in healthy participants, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• LY2963016 (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2014-10-07